TABLE 1.
Prevalence of resistance to ACV according to the immune status of the patients
| Virus excreted | Immunocompetent patients
|
Immunocompromised patients
|
Total patients
|
|||
|---|---|---|---|---|---|---|
| No. of patientsa | No. of strains | No. of patients | No. of strains | No. of patients | No. of strains | |
| HSV-1 | 1,237 (3 [0.2%]) | 1,326 | 1,168 (36 [3%]) | 1,523 | 2,405 (39 [1.6%]) | 2,848 |
| HSV-2 | 618 (3 [0.5%]) | 664 | 334 (18 [5.4%]) | 411 | 952 (21 [2.2%]) | 1,075 |
| Total | 1,855 (6 [0.3%]) | 1,990 | 1,502 (54 [3.6%]) | 1,933 | 3,357 (60 [1.8%]) | 3,923 |
a
The number and percentage of patients who excreted ACV-resistant HSV strains are given in parentheses.